{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:37:08Z","timestamp":1792888628910,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.19066","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T13:58:38Z","timestamp":1578664718000},"page":"e1919066","source":"Crossref","is-referenced-by-count":94,"title":["Association of Medicaid Expansion With Opioid Overdose Mortality in the United States"],"prefix":"10.1001","volume":"3","author":[{"given":"Nicole","family":"Kravitz-Wirtz","sequence":"first","affiliation":[{"name":"Violence Prevention Research Program, Department of Emergency Medicine, University of California Davis School of Medicine, Sacramento"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Davis","sequence":"additional","affiliation":[{"name":"Network for Public Health Law, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Ponicki","sequence":"additional","affiliation":[{"name":"Prevention Research Center, Pacific Institute for Research and Evaluation, Berkeley, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadne","family":"Rivera-Aguirre","sequence":"additional","affiliation":[{"name":"Center for Opioid Epidemiology and Policy, Department of Population Health, New York University School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia S.","family":"Martins","sequence":"additional","affiliation":[{"name":"Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[{"name":"Center for Opioid Epidemiology and Policy, Department of Population Health, New York University School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"issue":"329","key":"zoi190714r1","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999\u20132017.","author":"Hedegaard","year":"2018","journal-title":"NCHS Data Brief"},{"issue":"6S2","key":"zoi190714r5","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/j.amepre.2017.07.019","article-title":"Prevalence and medical costs of chronic diseases among adult Medicaid beneficiaries.","volume":"53","author":"Chapel","year":"2017","journal-title":"Am J Prev Med"},{"issue":"5","key":"zoi190714r6","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2105\/AJPH.2018.304338","article-title":"Impact of Medicaid expansion on access to opioid analgesic medications and medication-assisted treatment.","volume":"108","author":"Sharp","year":"2018","journal-title":"Am J Public Health"},{"issue":"4","key":"zoi190714r7","doi-asserted-by":"publisher","first-page":"e181588","DOI":"10.1001\/jamanetworkopen.2018.1588","article-title":"Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion.","volume":"1","author":"Saloner","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi190714r8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MLR.0000000000001054","article-title":"Medicaid expansion and prescription trends: opioids, addiction therapies, and other drugs.","volume":"57","author":"Cher","year":"2019","journal-title":"Med Care"},{"key":"zoi190714r9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jhealeco.2018.06.004","article-title":"The role of health insurance on treatment for opioid use disorders: evidence from the Affordable Care Act Medicaid expansion.","volume":"60","author":"Meinhofer","year":"2018","journal-title":"J Health Econ"},{"issue":"4","key":"zoi190714r11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/MLR.0000000000000703","article-title":"Impact of Medicaid expansion on Medicaid-covered utilization of buprenorphine for opioid use disorder treatment.","volume":"55","author":"Wen","year":"2017","journal-title":"Med Care"},{"key":"zoi190714r12","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"12","key":"zoi190714r13","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial.","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"zoi190714r14","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/add.v114.9","article-title":"The impact of expanded Medicaid eligibility on access to naloxone.","volume":"114","author":"Frank","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"zoi190714r15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11606-018-4664-7","article-title":"Early Medicaid expansions and drug overdose mortality in the USA: a quasi-experimental analysis.","volume":"34","author":"Venkataramani","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi190714r16","doi-asserted-by":"publisher","first-page":"e193056","DOI":"10.1001\/jamanetworkopen.2019.3056","article-title":"Association between state Medicaid eligibility thresholds and deaths due to substance use disorders.","volume":"2","author":"Snider","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi190714r17","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1111\/add.v114.11","article-title":"Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states.","volume":"114","author":"Swartz","year":"2019","journal-title":"Addiction"},{"key":"zoi190714r19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addbeh.2018.03.014","article-title":"Opioid-overdose laws association with opioid use and overdose mortality.","volume":"86","author":"McClellan","year":"2018","journal-title":"Addict Behav"},{"issue":"10","key":"zoi190714r20","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010.","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"11","key":"zoi190714r21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.7326\/M17-3074","article-title":"Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a systematic review.","volume":"168","author":"Fink","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi190714r23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.amepre.2017.06.009","article-title":"Geographic variation in opioid and heroin involved drug poisoning mortality rates.","volume":"53","author":"Ruhm","year":"2017","journal-title":"Am J Prev Med"},{"issue":"5","key":"zoi190714r25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.2041-210X.2012.00211.x","article-title":"Hierarchical analysis of spatially autocorrelated ecological data using integrated nested Laplace approximation.","volume":"3","author":"Beguin","year":"2012","journal-title":"Methods Ecol Evol"},{"key":"zoi190714r26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.sste.2015.08.001","article-title":"Comparing INLA and OpenBUGS for hierarchical Poisson modeling in disease mapping.","volume":"14-15","author":"Carroll","year":"2015","journal-title":"Spat Spatiotemporal Epidemiol"},{"issue":"7","key":"zoi190714r27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1001\/jamacardio.2019.1651","article-title":"Association of Medicaid expansion with cardiovascular mortality.","volume":"4","author":"Khatana","year":"2019","journal-title":"JAMA Cardiol"},{"key":"zoi190714r28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.drugalcdep.2017.07.015","article-title":"Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act.","volume":"179","author":"Feder","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"zoi190714r31","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1377\/hlthaff.2016.0623","article-title":"Survey highlights differences in medicaid coverage for substance use treatment and opioid use disorder medications.","volume":"35","author":"Grogan","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"zoi190714r33","doi-asserted-by":"publisher","first-page":"320","DOI":"10.15585\/mmwr.mm6612a2","article-title":"Methadone prescribing and overdose and the association with medicaid preferred drug list policies\u2014United States, 2007-2014.","volume":"66","author":"Faul","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi190714r2"},{"key":"zoi190714r3"},{"key":"zoi190714r10","volume-title":"The Opioid Epidemic and Medicaid\u2019s Role in Facilitating Access to Treatment","author":"Zur","year":"2018"},{"key":"zoi190714r18","volume-title":"Mortality\u2014All County, Micro-Data and Compressed, 2001-2017, for All States, as Compiled From Data Provided by the 57 Vital Statistics Jurisdictions Through the Vital Statistics Cooperative Program","author":"National Center for Health Statistics","year":"2017"},{"key":"zoi190714r24","doi-asserted-by":"crossref","DOI":"10.1002\/9781118950203","volume-title":"Spatial and Spatial-Temporal Bayesian Models with R-INLA","author":"Blangiardo","year":"2015"},{"key":"zoi190714r29","author":"Antonisse","year":"2018"},{"key":"zoi190714r30","volume-title":"Medicaid Coverage of Effective Treatment for Opioid Use Disorder","author":"Clemans-Cope","year":"2017"},{"key":"zoi190714r34","volume-title":"The Use of Methadone for Pain by Medicaid Patients: an Examination of Prescribing Patterns and Drug Use Policies","author":"Urahn","year":"2018"},{"key":"zoi190714r35","author":"Clemans-Cope","year":"2017"},{"key":"zoi190714r4","unstructured":"Henry J. Kaiser Family Foundation. Status of state action on the Medicaid expansion decision. https:\/\/www.kff.org\/health-reform\/state-indicator\/state-activity-around-expanding-medicaid-under-the-affordable-care-act\/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed April 20, 2018."},{"key":"zoi190714r22","unstructured":"Prescription Drug Abuse Policy System. http:\/\/pdaps.org\/. Accessed January 1, 2017."},{"key":"zoi190714r32","doi-asserted-by":"crossref","unstructured":"MattickRP, BreenC, KimberJ, DavoliM. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev.2014;(2):CD002207. doi:10.1002\/14651858.CD002207.pub4","DOI":"10.1002\/14651858.CD002207.pub4"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2758476\/kravitzwirtz_2020_oi_190714.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T13:58:41Z","timestamp":1578664721000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2758476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.19066","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]}}}